PPARγ as a new therapeutic in inflammatory bowel diseases

被引：354

作者：

Dubuquoy, L.

Rousseaux, C.

Thuru, X.

Peyrin, L. -Biroulet

Romano, O.

Chavatte, P.

Chamaillard, M.

Desreumaux, P.

机构：

[1] INSERM, Clin Digestif & Nutr Hosp, U795, E114, F-59037 Lille, France

[2] Univ Lille 2, F-59800 Lille, France

[3] CHRU Lille, Hosp Huriez, Serv Maladies Appareil Digetif & Nutr, Lille, France

[4] EA1043, Fac Sci Pharmaceut & Biol, Lab Chim Therapeut, Lille, France

来源：

GUT | 2006年 / 55卷 / 09期

关键词：

D O I：

10.1136/gut.2006.093484

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The peroxisome proliferator activated receptor gamma (PPAR gamma) is a nuclear receptor highly expressed in the colon and playing a key role in bacterial induced inflammation. Regulation of colon inflammation by this receptor has been well demonstrated in many experimental models of colitis but also in patients with ulcerative colitis, characterised by impaired expression of PPAR gamma confined to their colon epithelial cells. Recent data showing that PPAR gamma was the major functional receptor mediating the common aminosalicylate activities in inflammatory bowel diseases (IBD) have also reinforced the roles of this receptor in the control of intestinal inflammation. The aims of this review are to discuss the potential roles of PPAR gamma in the physiopathology of IBD, as well as the emerging therapeutic strategies targeting this receptor.

引用

收藏

页码：1341 / 1349

页数：9

相关论文

共 82 条

[1] Production of free conjugated linoleic acid by Lactobacillus acidophilus and Lactobacillus casei of human intestinal origin [J].

Alonso, L ;

Cuesta, EP ;

Gilliland, SE .

JOURNAL OF DAIRY SCIENCE, 2003, 86 (06) :1941-1946

[2]

Auwerx J, 1999, CELL, V97, P161

[3] Fatty acid transduction of nitric oxide signaling - Multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands [J].

Baker, PRS ;

Lin, YM ;

Schopfer, FJ ;

Woodcock, SR ;

Groeger, AL ;

Batthyany, C ;

Sweeney, S ;

Long, MH ;

Iles, KE ;

Baker, LMS ;

Branchaud, BP ;

Chen, YQE ;

Freeman, BA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (51) :42464-42475

[4] Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease [J].

Bassaganya-Riera, J ;

Reynolds, K ;

Martino-Catt, S ;

Cui, YZ ;

Hennighausen, L ;

Gonzalez, F ;

Rohrer, J ;

Benninghoff, AU ;

Hontecillas, R .

GASTROENTEROLOGY, 2004, 127 (03) :777-791

[5] Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity [J].

Berger, J ;

Tanen, M ;

Elbrecht, A ;

Hermanowski-Vosatka, A ;

Moller, DE ;

Wright, SD ;

Thieringer, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12629-12635

[6] Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line [J].

Bishop-Bailey, D ;

Hla, T ;

Warner, TD .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (04) :651-654

[7] Peroxisome proliferator activated receptor γ expression is reduced in the colonic mucosa of acromegalic patients. [J].

Bogazzi, F ;

Ultimieri, F ;

Raggi, F ;

Costa, A ;

Gasperi, M ;

Cecconi, E ;

Mosca, F ;

Bartalena, L ;

Martino, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2403-2406

[8] A yeast two-hybrid technology-based system for the discovery of PPARγ agonist and antagonist [J].

Chen, Q ;

Chen, J ;

Sun, T ;

Shen, JH ;

Shen, X ;

Jiang, HL .

ANALYTICAL BIOCHEMISTRY, 2004, 335 (02) :253-259

[9] Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut [J].

Cuzzocrea, S ;

Pisano, B ;

Dugo, L ;

Ianaro, A ;

Patel, NSA ;

Di Paola, R ;

Genovese, T ;

Chatterjee, PK ;

Di Rosa, M ;

Caputi, AP ;

Thiemermann, C .

BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :366-376

[10] The pleiotropic functions of peroxisome proliferator-activated receptor γ [J].

Debril, MB ;

Renaud, JP ;

Fajas, L ;

Auwerx, J .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (01) :30-47

← 1 2 3 4 5 6 7 8 9 →